256 related articles for article (PubMed ID: 6538442)
1. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
Broderick PA; Gardner EL; van Praag HM
Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
[TBL] [Abstract][Full Text] [Related]
2. Similar effects of an enkephalin analog on mesolimbic dopamine release and hyperactivity in rats.
Broderick PA; Gardner EL; van Praag HM
Life Sci; 1983; 33 Suppl 1():635-8. PubMed ID: 6686641
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms involved in the stereotyped behavior elicited by amphetamine.
Groves PM
Biol Psychiatry; 1977 Jun; 12(3):381-8. PubMed ID: 194632
[TBL] [Abstract][Full Text] [Related]
5. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
6. In vivo electrochemical evidence for an enkephalinergic modulation underlying stereotyped behavior: reversibility by naloxone.
Broderick PA; Blaha CD; Lane RF
Brain Res; 1983 Jun; 269(2):378-81. PubMed ID: 6683987
[TBL] [Abstract][Full Text] [Related]
7. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
Koob GF; Del Fiacco M; Iversen SD
Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
[No Abstract] [Full Text] [Related]
8. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
[TBL] [Abstract][Full Text] [Related]
9. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
[No Abstract] [Full Text] [Related]
10. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
Yehuda S
Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
[No Abstract] [Full Text] [Related]
11. Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction?
Turski L; Schwarz M; Sontag KH
Behav Brain Res; 1984 Apr; 12(1):29-37. PubMed ID: 6539616
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
Lynch MR; Carey RJ
Behav Brain Res; 1989 Feb; 32(1):69-74. PubMed ID: 2495013
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of amphetamine-stereotypy by mesostriatal dopamine depletion enhances plasma corticosterone: implications for stereotypy as a coping response.
Jones GH; Mittleman G; Robbins TW
Behav Neural Biol; 1989 Jan; 51(1):80-91. PubMed ID: 2705984
[TBL] [Abstract][Full Text] [Related]
14. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.
Chandra G; Gangopadhyay PK; Senthil Kumar KS; Mohanakumar KP
Brain Res; 2006 Feb; 1075(1):81-92. PubMed ID: 16487496
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
Johnson KM
Fed Proc; 1983 Jun; 42(9):2579-83. PubMed ID: 6133782
[TBL] [Abstract][Full Text] [Related]
16. Short term augmentation of amphetamine-induced rotation bias.
Elias JW; Yandell LR; Graff R; Albrecht JW; Smith CJ
Physiol Behav; 1983 Nov; 31(5):639-42. PubMed ID: 6686683
[TBL] [Abstract][Full Text] [Related]
17. The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.
de Yebenes JG; Fahn S; Jackson-Lewis V; Mena MA
Mov Disord; 1987; 2(4):291-9. PubMed ID: 2904650
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
Dougherty GG; Ellinwood EH
Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
[TBL] [Abstract][Full Text] [Related]
19. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
[No Abstract] [Full Text] [Related]
20. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
Sindhu KM; Saravanan KS; Mohanakumar KP
Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
